It is the twentieth anniversary of the new patent act in January 2025. The post-patent (P20) era is a story of resilience, determination, and charting a course that set global ambitions, a story of finding opportunity in adversity. It is a story for case studies in business schools, in international studies, in global health efforts.
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic use. It has a well-documented...
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends affordable medicines to millions of Americans, saving the U.S. healthcare...
KKR's Investments in India's Medical Devices Market: Strategic Implications and Key Investors
Introduction
The Indian medical devices sector is witnessing unprecedented...
India pharma is crucial for global healthcare, providing affordable medicines worldwide.India's pharma companies excel in domestic markets and international...
India's top 10 pharma companies by market capitalization, offering insights into their valuation, revenue performance, and industry trends
In 2025, the Indian...
Introduction
For decades, leaders and organizations have relied on the VUCA framework—Volatility, Uncertainty, Complexity, and Ambiguity—to understand and respond to...